Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Receptagen Ltd. -- Ignore unavailable to you. Want to Upgrade?

To: Russell J. Gilbert who wrote (115)	7/17/1998 9:49:00 PM
From: Russell J. Gilbert	Read Replies (1) \| Respond to of 203

Receptagen went a little wild this week especially yesterday when 265,000 shares traded. I spoke with Warren Wheeler today at Receptagen and he said the merger with Global Research Network (GRN) is moving right on track. Has anyone who reads this thread tried to contact GRN in Canada. It sure would be great if you could post it here so we can get as much information as possible. I know people read some of my posts because Warren Wheeler said that when shareholders call him they mention my name about my posts. So, if you read these, PLEASE post your thoughts right here and on Stockhouse. I see a teriffic opportunity going on right here. As long as the merger deal doesn't die between RCEPF and GRN then this is a screaming buy. If the deal falls through then it"s bye bye, adios, so long, hasta manana,! But I do not believe this is going to happen. I think the merger is going to go and the stock should go around .10-.20 level U.S. per share pre-consolidation and that would mean a $2.00 - $4.00 per share post consolidation. PLEASE POST IT HERE FOLKS!